Novavax
NVAX
#5737
Rank
NZ$2.31 B
Marketcap
NZ$14.04
Share price
-3.02%
Change (1 day)
20.96%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -NZ$0.39 Billion

According to Novavax's latest financial reports the company's current earnings are NZ$0.41 Billion. In 2025 the company made an earning of NZ$0.84 Billion, an increase over its 2024 earnings that were of -NZ$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.39 Billion-145.8%
2025 NZ$0.84 B-396.87%
2024 -NZ$0.29 Billion-70.39%
2023 -NZ$0.97 Billion-16.59%
2022 -NZ$1.16 Billion-62.58%
2021 -NZ$3.09 Billion320.54%
2020 -NZ$0.74 Billion234.22%
2019 -NZ$0.22 Billion-30.17%
2018 -NZ$0.32 Billion1.69%
2017 -NZ$0.31 Billion-36.44%
2016 -NZ$0.49 Billion70.4%
2015 -NZ$0.29 Billion89.27%
2014 -NZ$0.16 Billion59.83%
2013 -NZ$94.23 Million81.9%
2012 -NZ$51.8 Million50.33%
2011 -NZ$34.46 Million
2009 -NZ$68 Million8.8%
2008 -NZ$62.51 Million18.01%
2007 -NZ$52.97 Million18.33%
2006 -NZ$44.77 Million168.31%
2005 -NZ$16.69 Million-62.51%
2004 -NZ$44.51 Million52.4%
2003 -NZ$29.21 Million-28.21%
2002 -NZ$40.68 Million
2000 -NZ$23.18 Million177%
1999 -NZ$8.37 Million-11.54%
1998 -NZ$9.46 Million10.64%
1997 -NZ$8.55 Million-9.62%
1996 -NZ$9.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$22.99 B-5,758.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.67 B-3,218.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$27.44 B-6,853.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$13.01 B-3,302.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.6 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.27 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$14.95 Million-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.65 Billion 58.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.36 Billion-12.90%๐Ÿ‡บ๐Ÿ‡ธ USA